Search results for "Globin"

showing 10 items of 734 documents

Adding insulin glargine vs. NPH insulin to metformin results in a more efficient postprandial β-cell protection in individuals with type 2 diabetes

2010

AIM Postprandial release of intact proinsulin (IP) is an independent marker for beta-cell dysfunction in patients with type 2 diabetes. This open-label, parallel-group, two-arm, pilot study compared the beta-cell protective effect of adding insulin glargine (GLA) vs. NPH insulin to ongoing metformin. MATERIAL AND METHODS Overall, 28 insulin-naive type 2 diabetes subjects (mean +/- SD age, 61.5 +/- 6.7 years; diabetes duration, 9.8 +/- 6.5 years; HbA1c, 7.1 +/- 0.5%; BMI, 30.7 +/- 4.3 kg/m(2)) treated with metformin and sulfonylurea were randomized to add once-daily GLA or NPH at bedtime. At baseline and after 3 months, subjects received a standardized breakfast, lunch and dinner, with pre- …

Malemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentInsulin IsophaneInsulin GlarginePilot ProjectsNPH insulinType 2 diabetesNPH insulinDrug Administration ScheduleEndocrinologyInsulin-Secreting CellsInternal medicineDiabetes mellitusInternal MedicinemedicineHumansHypoglycemic AgentsInsulinintact proinsulinGlycated Hemoglobinbusiness.industryInsulin glargineInsulindigestive oral and skin physiologynutritional and metabolic diseasesFastingOriginal ArticlesMiddle AgedPostprandial Periodmedicine.diseaseMetforminMetforminInsulin Long-ActingEndocrinologyPostprandialDiabetes Mellitus Type 2beta cell stressDrug Therapy CombinationFemalebusinessmedicine.drugBlood samplingDiabetes, Obesity and Metabolism
researchProduct

Biochemical risk indices, including plasma homocysteine, that prospectively predict mortality in older British people: the National Diet and Nutritio…

2010

Predictive power, for total and vascular mortality, of selected indices measured at baseline in the British National Diet and Nutrition Survey (community-living subset) of People Aged 65 Years and Over was tested. Mortality status and its primary and underlying causes were recorded for 1100 (mean age 76·7 (sd7·5) years, 50·2 % females) respondents from the baseline survey in 1994–5 until September 2008. Follow-up data analyses focussed especially on known predictors of vascular disease risk, together with intakes and status indices of selected nutrients known to affect, or to be affected by, these predictors. Total mortality was significantly predicted by hazard ratios of baseline plasma co…

Malemedicine.medical_specialtyHomocysteineMedicine (miscellaneous)Nutritional StatusDiet SurveysArticlechemistry.chemical_compoundRisk FactorsInternal medicineMedicineChymotrypsinHumansVitamin B12Vascular DiseasesRisk factorMortalityHomocysteineSurvival analysisAgedProportional Hazards ModelsAged 80 and overGlycated HemoglobinCreatinineNutrition and Dieteticsbusiness.industryProportional hazards modelHazard ratioFibrinogenPrognosisSurvival AnalysisUnited KingdomB vitaminsEndocrinologyCholesterolchemistryCreatinineVitamin B ComplexFemaleDietary ProteinsbusinessEnergy IntakeBiomarkersDemographyThe British journal of nutrition
researchProduct

Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility

2020

Abstract Background The Sars-CoV-2 can cause severe pneumonia with multiorgan disease; thus, the identification of clinical and laboratory predictors of the progression towards severe and fatal forms of this illness is needed. Here, we retrospectively evaluated and integrated laboratory parameters of 45 elderly subjects from a long-term care facility with Sars-CoV-2 outbreak and spread, to identify potential common patterns of systemic response able to better stratify patients’ clinical course and outcome. Methods Baseline white blood cells, granulocytes’, lymphocytes’, and platelets’ counts, hemoglobin, total iron, ferritin, D-dimer, and interleukin-6 concentration were used to generate a …

Malemedicine.medical_specialtyLymphocyteIronlcsh:MedicineDiseaseMonocyteGeneral Biochemistry Genetics and Molecular BiologyMonocytesFibrin Fibrinogen Degradation ProductsLeukocyte CountLong-term care facilitieInternal medicineD-dimermedicineHumansLymphocytesAgedRetrospective StudiesAged 80 and overbiologybusiness.industryPlatelet CountLong-term care facilitiesClinical outcomeSARS-CoV-2MonocyteResearchlcsh:RCOVID-19Retrospective cohort studyGeneral MedicineBiomarkerMiddle Agedmedicine.diseasePrognosisLong-Term CareFerritinPneumoniamedicine.anatomical_structureTreatment OutcomeD-dimerbiology.proteinFemaleLymphocyteHemoglobinbusinessBiomarkers
researchProduct

Remission phase in children diagnosed with type 1 diabetes in years 2012 to 2013 in Silesia, Poland: An observational study

2018

Background/objective The study aimed to analyze the frequency of partial remission (PR) and its association with chosen clinical and laboratory factors among pediatric patients with newly diagnosed type 1 diabetes (T1D). The long-term effect of PR on chosen parameters was also investigated. Methods In 194 patients (95 girls) aged 8.1 ± 4.3 years, we analyzed data at T1D onset: glycemia, pH, C-peptide, antibodies, weight, and concomitant autoimmune diseases. Anthropometric parameters, daily insulin requirement (DIR), and HbA1c 2 and 4 years after T1D diagnosis were also analyzed. We determined PR based on HbA1c and DIR measurements at least every 3 months. Results PR occurred in 59% of patie…

Malemedicine.medical_specialtyMultivariate analysisAdolescentEndocrinology Diabetes and Metabolismmedicine.medical_treatment030209 endocrinology & metabolismGastroenterologyDiabetic Ketoacidosis03 medical and health sciences0302 clinical medicineInternal medicineRemission phaseInternal MedicinemedicineHumans030212 general & internal medicineAge of OnsetChildGlycated HemoglobinType 1 diabetesbusiness.industryInsulinRemission InductionAge Factorsmedicine.diseaseKetoacidosisDiabetes Mellitus Type 1Child PreschoolConcomitantPediatrics Perinatology and Child HealthFemaleObservational studyPolandbusinessBody mass indexPediatric Diabetes
researchProduct

Minor hepatic resection using heat coagulative necrosis

2009

Intra- and postoperative bleeding represents an extremely serious and frequent complication of hepatic surgery. In this study, we evaluated the effectiveness of a radiofrequency (RF) device using heat to cause coagulative necrosis of the hepatic parenchyma to control hemostasis in minor hepatic resection. Between December 2005 and November 2007, a study was conducted of 21 patients undergoing 22 hepatic resections with the RF-assisted technique. Sixteen of these were affected by hepatocellular carcinoma and five had liver metastases from colorectal cancer. Intraoperative blood loss, the need for blood transfusion, the complication rates, operating times, and the duration of postoperative h…

Malemedicine.medical_specialtyNecrosisBlood transfusionCarcinoma HepatocellularColorectal cancermedicine.medical_treatmentBlood Loss SurgicalHemoglobinsmedicineliver metastases cancer surgeryHepatectomyHumansAgedbusiness.industryLiver NeoplasmsGeneral MedicineLength of StayMiddle Agedmedicine.diseaseHemostasis SurgicalSurgerySettore MED/18 - Chirurgia GeneraleCoagulative necrosisHematocritHemostasisAnesthesiaHepatocellular carcinomaCatheter AblationFemalemedicine.symptomHepatectomyComplicationbusiness
researchProduct

Oxygen-haemoglobin dissociation curve in hypoxic rats of first or second generation.

1993

SUMMARY 1. Albino Wistar rats were raised in a normobaric hypoxic environment (10% O2 in N2). Two generations of hypoxic rats were observed for changes in their haemoglobin-oxygen (Hb-O2) dissociation curves (ODC), 2,3-diphosphoglycerate (2,3-DPG), haemoglobin (Hb), and Hill coefficients at P50 (n50). The first generation were called (H1) and the second generation (H2). The control group (N) had a normoxic environment. 2. Thirty-five rats (13 N rats, 12 H1 rats and 10 H2 rats) were used. The 2,3-DPG was significantly higher in both hypoxic groups when compared with N rats (2.02 ± 0.51 mmol/L) but 2,3-DPG of H2 rats was significantly lower than that of H1 rats (H1 = 3.48±0.58 mmol/L and H2 =…

Malemedicine.medical_specialtyP50PhysiologyHypoxic hypoxiaOxygenepCO2HemoglobinsPhysiology (medical)Internal medicineMolemedicineAnimalsRats WistarHypoxiacomputer.programming_languagePharmacology23-DiphosphoglycerateAcid-Base EquilibriumChemistryOxygen–haemoglobin dissociation curveCarbon DioxideDiphosphoglyceric AcidsRatsOxygenEndocrinologyTissue oxygenationBiochemistryFemaleHemoglobincomputerClinical and experimental pharmacologyphysiology
researchProduct

Acute painful paraplegia in a 49-year-old man with allergic asthma.

2014

We present a case of a 49-year-old man, with a 10-year history of bronchial asthma and nasal polyposis, who developed acutely painful paraplegia and paresthesias. Laboratory data showed elevated blood creatine kinase levels and myoglobinuria, which were diagnostic for rhabdomyolysis but only partially explained the neurological deficit. Electrophysiological studies revealed a sensorimotor neuropathy of multiple mononeuritis type. The patient also had leucocytosis with marked eosinophilia and antineutrophil cytoplasmic autoantibodies. Bronchial biopsies showed inflammatory infiltrates with a prevalence of eosinophils. All these findings led us to diagnose eosinophilic granulomatosis with pol…

Malemedicine.medical_specialtyPathologyChurg-Strauss SyndromeRhabdomyolysisArticleNasal PolypsEosinophilicRespiratory medicine Asthma Pneumonia Rheumatology VasculitismedicineEosinophiliaHumansParesthesiaLungAsthmaParaplegiabusiness.industryMyoglobinuriaGeneral MedicineMyalgiaMiddle Agedmedicine.diseaseDermatologyRhinitis AllergicAsthmaRadiographymedicine.symptomDifferential diagnosisGranulomatosis with polyangiitisbusinessRhabdomyolysisSystemic vasculitisBMJ case reports
researchProduct

The Role of Tumor Volume in ‘Reoxygenation’ upon Cyclophosphamide Treatment

1995

The effect of cyclophosphamide (CP) injection (60 mg/kg i.p., single dose) on volume growth and tissue oxygenation (pO2 distribution) was investigated in rat DS-sarcomas. CP was administered 4 days after subcutaneous (s.c.) tumor implantation (volume approximately 0.35 ml). Polarographic pO2 measurements were performed in the subcutis at the hind foot dorsum and in tumors 72 h after CP administration. The oxygenation status of these tissues was compared with that of saline-treated controls. CP-injection caused a mean growth delay of 11 days in DS-sarcomas and had no impact on the oxygenation status of the subcutis. In contrast, in s.c. growing DS-sarcomas the pO2 distribution improved signi…

Malemedicine.medical_specialtyPathologyTime FactorsCyclophosphamidePartial PressureUrologyBlood PressureHematocritRats Sprague-DawleyHemoglobinsOxygen ConsumptionAnimalsMedicineDistribution (pharmacology)Radiology Nuclear Medicine and imagingCyclophosphamidemedicine.diagnostic_testbusiness.industryTumor shrinkageHematologyGeneral MedicineOxygenationCarbon Dioxidemedicine.diseaseCyclophosphamide treatmentRatsOxygenKineticsHematocritOncologyVolume (thermodynamics)FemaleSarcoma ExperimentalSarcomabusinessCell DivisionPolarographymedicine.drugActa Oncologica
researchProduct

Elastase, myeloperoxidase, nitric oxide metabolites and oxidative status in subjects with clinical stable chronic renal failure on conservative treat…

2009

We evaluated, in a group of 41 CRF undialyzed subjects (29 men and 12 women, mean age 64.1 +/- 11.3 years), some parameters that reflect leukocyte activation (elastase, myeloperoxidase - MPO), plasma NO metabolites (NO(x)) and the oxidative status (lipid peroxidation expressed as thiobarbituric acid-reactive substances (TBARS) and total antioxidant status (TAS). Elastase was determined, on plasma separated from fasting venous blood, as elastase/alpha1-proteinase inhibitor complex. MPO was evaluated employing the Myeloperoxidase ELISA kit. The NO production was evaluated by a micromethod. The oxidation of polyunsaturated fatty acids was evaluated in plasma by detection of the thiobarbituric …

Malemedicine.medical_specialtyPhysiologyRenal functionThiobarbituric Acid Reactive SubstancesLipid peroxidationchemistry.chemical_compoundchronic renal failurenitric oxidePhysiology (medical)Internal medicineTBARSLeukocytesMedicineHumanselastaseAgedPeroxidasechemistry.chemical_classificationCreatininebiologyPancreatic Elastasebusiness.industryElastaseHematologyMiddle Agedoxidative statuOxidative StressmyeloperoxidaseEndocrinologychemistrySpectrophotometryMyeloperoxidaseCase-Control StudiesImmunologybiology.proteinKidney Failure ChronicFemaleHemoglobinCardiology and Cardiovascular MedicinebusinessPolyunsaturated fatty acid
researchProduct

Postischemic application of lipid peroxidation inhibitor U-101033E reduces neuronal damage after global cerebral ischemia in rats.

1998

Background and Purpose —The lipid peroxidation inhibitor U-101033E was examined for effects on cerebral blood flow (CBF), cortical tissue hemoglobin oxygen saturation (HbS o 2 ), and neuronal damage. Methods —Fifteen minutes of global cerebral ischemia was induced by two-vessel occlusion and hypobaric hypotension. Wistar rats (n=25) were randomized to receive vehicle (n=9) or 40 mg/kg U-101033E (n=9) intraperitoneally during 2 hours of reperfusion. A sham group (n=7) had neither ischemia nor therapy. Histology was evaluated 7 days after ischemia. Results —During late hyperperfusion (at 17 minutes), vehicle-treated animals had a higher ( P =0.044) cortical tissue HbS o 2 (72.0±1.4%) than di…

Malemedicine.medical_specialtyPyrrolidinesVasodilator AgentsIschemiaCell CountHippocampal formationAntioxidantsCentral nervous system diseaseLipid peroxidationchemistry.chemical_compoundCortex (anatomy)Internal medicinemedicineLaser-Doppler FlowmetryAnimalsRats WistarAdvanced and Specialized NursingNeuronsbusiness.industryCarbon Dioxidemedicine.diseaseSurgeryRatsEndocrinologymedicine.anatomical_structureNeuroprotective AgentsPyrimidinesCerebral blood flowchemistryCerebral cortexIschemic Attack TransientCerebrovascular CirculationOxyhemoglobinsNeurology (clinical)Lipid PeroxidationHypotensionCardiology and Cardiovascular MedicinebusinessReperfusion injuryStroke
researchProduct